PPARG and hepatocellular carcinoma: Since no differences were found dependent on genotypes, gender (HCC) and treatments (SHAM; CNP-24 h; CNP-72 h) as far as BAL cell populations were concerned, we next set to investigate whether PPARγ mutations may affect the recruitment of immuno-competent leukocytes into the blood stream.